Notice of Meetings, 102909 [2024-29969]

Download as PDF 102909 Federal Register / Vol. 89, No. 243 / Wednesday, December 18, 2024 / Notices under method 1 are based on data collected by the Basel Committee on Banking Supervision (BCBS). The BCBS amounts are determined based on the sum of the systemic indicator amounts as reported by the 75 largest U.S. and foreign banking organizations as measured by the BCBS, and any other banking organization that the BCBS includes in its sample total for that year. The BCBS publicly releases these amounts, denominated in euros, each year.3 Pursuant to the GSIB surcharge rule, the Board publishes the aggregate global indicator amounts each year as denominated in U.S. dollars using the euro-dollar exchange rate provided by the BCBS.4 Specifically, to determine the 2024 aggregate global indicator amounts, the Board uses the year-end 2023 euro-denominated indicator amounts published by the BCBS and multiplies each of the eurodenominated indicator amounts by 1.105, the euro to U.S. dollar spot exchange rate on December 31, 2023.5 The aggregate global indicator amounts expressed in U.S. dollars for purposes of the 2024 method 1 score calculation under § 217.404(b)(1)(i)(B) of the GSIB surcharge rule are: AGGREGATE GLOBAL INDICATOR AMOUNTS IN U.S. DOLLARS (USD) FOR 2024 Systemic indicator Size ........................................................................ Interconnectedness ............................................... Total exposures ............................................................................... Intra-financial system assets ........................................................... Intra-financial system liabilities ........................................................ Securities outstanding ..................................................................... Payments activity ............................................................................ Assets under custody ...................................................................... Underwritten transactions in debt and equity markets ................... Notional amount of over-the-counter (OTC) derivatives ................. Trading and available-for-sale (AFS) securities .............................. Level 3 assets ................................................................................. Cross-jurisdictional claims ............................................................... Cross-jurisdictional liabilities ........................................................... Substitutability ........................................................ Complexity ............................................................. Cross-jurisdictional activity .................................... Authority: 12 U.S.C. 248(a), 321–338a, 481–486, 1462a, 1467a, 1818, 1828, 1831n, 1831o, 1831p–l, 1831w, 1835, 1844(b), 1851, 3904, 3906–3909, 4808, 5365, 5368, 5371. By order of the Board of Governors of the Federal Reserve System, acting through the Director of Supervision and Regulation under delegated authority. Ann E. Misback, Secretary of the Board. [FR Doc. 2024–29981 Filed 12–17–24; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meetings Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Notice of five AHRQ subcommittee meetings. AGENCY: The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group (IRG) Committee. Grant applications are SUMMARY: khammond on DSK9W7S144PROD with NOTICES Aggregate global indicator amount (in USD) Category 3 The data used by the Board are available on the BCBS website at https://www.bis.org/bcbs/gsib/ denominators.htm. 4 12 CFR 217.404(b)(1)(i)(B); see also 80 FR 49082, 49086–87 (August 14, 2015). In addition, the Board VerDate Sep<11>2014 18:09 Dec 17, 2024 Jkt 265001 to be reviewed and discussed at these meetings. Each subcommittee meeting will be closed to the public. DATES: See below for dates of meetings: 1. Healthcare Safety and Quality Improvement Research (HSQR). Date: February 5–6, 2025. 2. Healthcare Effectiveness and Outcomes Research (HEOR). Date: February 5–6, 2025. 3. Health System and Value Research (HSVR). Date: February 13–14, 2025. 4. Healthcare Research Training (HCRT). Date: February 27–28, 2025. 5. Healthcare Information Technology Research (HITR). Date: February 27–28, 2025. ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: (to obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.)Jenny Griffith, Committee Management Officer, Division of Policy, Coordination and Analysis, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, maintains the GSIB Framework Denominators on its website, available at https:// www.federalreserve.gov/supervisionreg/basel/ denominators.htm. PO 00000 Frm 00058 Fmt 4703 Sfmt 9990 $115,205,051,188,518 11,253,226,663,114 11,388,383,441,235 19,247,590,871,111 3,527,103,136,881,927 219,479,268,261,988 7,962,804,019,185 733,514,990,056,729 4,278,831,961,372 803,127,442,989 28,416,427,492,687 23,524,643,383,930 Rockville, Maryland 20857, telephone (301) 427–1557. In accordance with the Federal Advisory Committee Act, 5 U.S.C. 1009(a)(2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. SUPPLEMENTARY INFORMATION: Dated: December 12, 2024. Marquita Cullom, Associate Director. [FR Doc. 2024–29969 Filed 12–17–24; 8:45 am] BILLING CODE 4160–90–P 5 Foreign exchange rates provided by the BCBS. Available at https://www.bis.org/bcbs/gsib/ reporting_instructions.htm. E:\FR\FM\18DEN1.SGM 18DEN1

Agencies

[Federal Register Volume 89, Number 243 (Wednesday, December 18, 2024)]
[Notices]
[Page 102909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29969]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meetings

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services (HHS).

ACTION: Notice of five AHRQ subcommittee meetings.

-----------------------------------------------------------------------

SUMMARY: The subcommittees listed below are part of AHRQ's Health 
Services Research Initial Review Group (IRG) Committee. Grant 
applications are to be reviewed and discussed at these meetings. Each 
subcommittee meeting will be closed to the public.

DATES: See below for dates of meetings:
    1. Healthcare Safety and Quality Improvement Research (HSQR).
    Date: February 5-6, 2025.
    2. Healthcare Effectiveness and Outcomes Research (HEOR).
    Date: February 5-6, 2025.
    3. Health System and Value Research (HSVR).
    Date: February 13-14, 2025.
    4. Healthcare Research Training (HCRT).
    Date: February 27-28, 2025.
    5. Healthcare Information Technology Research (HITR).
    Date: February 27-28, 2025.

ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 
5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: (to obtain a roster of members, agenda 
or minutes of the non-confidential portions of the meetings.)Jenny 
Griffith, Committee Management Officer, Division of Policy, 
Coordination and Analysis, Office of Extramural Research Education and 
Priority Populations, Agency for Healthcare Research and Quality 
(AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, telephone (301) 
427-1557.

SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory 
Committee Act, 5 U.S.C. 1009(a)(2), AHRQ announces meetings of the 
above-listed scientific peer review groups, which are subcommittees of 
AHRQ's Health Services Research Initial Review Group Committee. The 
subcommittee meetings will be closed to the public in accordance with 
the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4), and 
5 U.S.C. 552b(c)(6). The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Agenda items for these meetings are subject to change as priorities 
dictate.

    Dated: December 12, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024-29969 Filed 12-17-24; 8:45 am]
BILLING CODE 4160-90-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.